Page 115 - Molecular features of low-grade developmental brain tumours

THE CODING AND NON-CODING TRANSCRIPTIONAL LANDSCAPE OF SEGA
References
1. van Slegtenhorst, M. et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277, 805-808 (1997).
2. DiMario, F. J., Jr. Brain abnormalities in tuberous sclerosis complex. J Child Neurol 19, 650-657 (2004).
3. European Chromosome 16 Tuberous Sclerosis, C. Identification and characterization of the
tuberous sclerosis gene on chromosome 16. Cell 75, 1305-1315 (1993).
4. Mizuguchi, M. & Takashima, S. Neuropathology of tuberous sclerosis. Brain Dev 23, 508-515 (2001).
5. Aronica, E., Becker, A. J. & Spreafico, R. Malformations of cortical development. Brain Pathol 22, 380-
401, doi:10.1111/j.1750-3639.2012.00581.x (2012).
6. Aronica, E. & Crino, P. B. Epilepsy related to developmental tumors and malformations of cortical
development. Neurotherapeutics 11, 251-268, doi:10.1007/s13311-013-0251-0 (2014).
7. Jozwiak, S., Mandera, M. & Mlynarski, W. Natural History and Current Treatment Options for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex. Semin Pediatr Neurol 22,
274-281, doi:10.1016/j.spen.2015.10.003 (2015).
8. Louis, D. N. et al. The 2016 World Health Organization Classification of Tumors of the Central
Nervous System: a summary. Acta neuropathologica 131, 803-820, doi:10.1007/s00401-016-1545-1
(2016).
9. Kothare, S. V. et al. Severity of manifestations in tuberous sclerosis complex in relation to genotype.
Epilepsia 55, 1025-1029, doi:10.1111/epi.12680 (2014).
10. Kingswood, J. C. et al. TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline
data on 2093 patients. Orphanet J Rare Dis 12, 2, doi:10.1186/s13023-016-0553-5 (2017).
11. Goh, S., Butler, W. & Thiele, E. A. Subependymal giant cell tumors in tuberous sclerosis complex.
Neurology 63, 1457-1461 (2004).
12. Cuccia, V. et al. Subependymal giant cell astrocytoma in children with tuberous sclerosis. Childs Nerv
Syst 19, 232-243, doi:10.1007/s00381-002-0700-2 (2003).
13. Adriaensen, M. E. et al. Prevalence of subependymal giant cell tumors in patients with
tuberous sclerosis and a review of the literature. Eur J Neurol 16, 691-696, doi:10.1111/j.1468-
1331.2009.02567.x (2009).
14. Morimoto, K. & Mogami, H. Sequential CT study of subependymal giant-cell astrocytoma associated
with tuberous sclerosis. Case report. J Neurosurg 65, 874-877, doi:10.3171/jns.1986.65.6.0874
(1986).
15. Nabbout, R. et al. Early diagnosis of subependymal giant cell astrocytoma in children with tuberous
sclerosis. J Neurol Neurosurg Psychiatry 66, 370-375 (1999).
16. Fujiwara, S., Takaki, T., Hikita, T. & Nishio, S. Subependymal giant-cell astrocytoma associated with
tuberous sclerosis. Do subependymal nodules grow? Childs Nerv Syst 5, 43-44 (1989).
17. Kotulska, K. et al. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis
complex patients. Pediatr Neurol 50, 307-312, doi:10.1016/j.pediatrneurol.2013.12.004 (2014).
18. de Ribaupierre, S. et al. Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate? Neurosurgery 60, 83-89; discussion 89-90, doi:10.1227/01.
NEU.0000249216.19591.5D (2007).
19. Sancak, Y. et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science
320, 1496-1501, doi:10.1126/science.1157535 (2008).
20. Dibble, C. C. et al. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol
Cell 47, 535-546, doi:10.1016/j.molcel.2012.06.009 (2012).
21. Inoki, K., Li, Y., Xu, T. & Guan, K. L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates
113
4